SEC Company Response from Ensysce Biosciences, Inc. (ENSC, ENSCW) (CIK 0001716947) (ENSC) — Dec 1, 2017
Ensysce Biosciences, Inc. (ENSC, ENSCW) (CIK 0001716947)
Date: Dec. 1, 2017 · CIK: 0001716947 · Accession: 0001144204-17-061789
AI Filing Summary & Sentiment
File numbers found in text: 333-221330
Show Raw Text
CORRESP
1
filename1.htm
December 1, 2017
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Larry Spirgel
Re: Leisure Acquisition Corp.
Registration Statement on Form S-1
Filed November 3, 2017, as amended
File No. 333-221330
Dear Mr. Spirgel:
Pursuant to Rule 461 of the General Rules and Regulations under
the Securities Act of 1933, as amended (the “Act”), the undersigned, for itself and the several underwriters, hereby
joins in the request of Leisure Acquisition Corp. that the effective date of the above-referenced Registration Statement not occur
on November 30, 2017, as previously requested in our letter to you dated November 28, 2017, and instead be accelerated so as to
permit it to become effective at 9:00 a.m. Washington D.C. time on December 1, 2017, or as soon thereafter as practicable.
* * *
[signature page follows]
Very truly yours,
Morgan Stanley & Co. LLC,
as Representative of the Several Underwriters
By:
/s/ Jon Sierant
Name:
Jon Sierant
Title:
Executive Director
[Signature Page to Underwriter Acceleration
Request Letter]